Nautilus Bio
IPOSan Diego, United States · $113.6M raised
- Headquarters
- San Diego, California
- Business Model
- B2B
- Total Funding
- $113.6M
- Last Round
- $76.0M Series BMay 2020
- Rounds
- 2
About
Biotechnology company developing a single-molecule proteomics platform to identify and quantify proteins at scale.
Summary
Nautilus Bio is a Biotech company based in San Diego, United States. It has raised $113.6M in total across 2 rounds, most recently a $76.0M Series B round in May 2020. Investors include Perceptive Advisors, Vulcan Capital and Andreessen Horowitz.
Tech & App Stack
6 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.